- CA$1.12bn
- CA$1.29bn
- CA$1.47bn
- 90
- 69
- 97
- 98
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.86 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -3.12% | ||
| Dividend Yield (f) | 3.79% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9 | ||
| Price to Tang. Book | 324.81 | ||
| Price to Free Cashflow | 11 | ||
| Price to Sales | 0.76 | ||
| EV to EBITDA | 8.8 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 26.89% | ||
| Return on Equity | 70.86% | ||
| Operating Margin | 7.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 1,103.54 | 1,166.99 | 1,221.58 | 1,304.96 | 1,466.2 | 1,539.69 | 1,619.53 | 5.31% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -1.22 | +247.86 | +99.52 | -10.48 | +14.53 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Extendicare Inc. is a provider of care and services for seniors across Canada. The Company operates under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The Company operates through four segments: Long-term Care, Home Health Care, Managed Services and Corporate. Its Long-term Care segment includes over 53 long-term care homes, which it owns and operates in Canada. Its Home Health Care segment operates through its subsidiary, ParaMed, which provides complex nursing care, occupational, physical and speech therapy, and assistance with daily activities. Its Managed Services segment includes its management, consulting and group purchasing divisions. Through the Extendicare Assist division, it provides management and consulting services to third parties, and through the SGP Purchasing Partner Network division, it offers purchasing contracts to other senior care providers for food, capital equipment, furnishings, cleaning, nursing supplies, and more.
Directors
- Alan Torrie NEC (69)
- Michael Guerriere PRE (57)
- David Bacon CFO
- Liselie Sarauer CHO
- John Toffoletto SVP
- Jillian Fountain VPR
- Elaine Everson VPR
- Ali Mir VPR
- Lisa Pearson VPR
- Norma Beauchamp IND (59)
- Sandra Hanington IND (59)
- Alan Hibben IND (68)
- Brent Houlden IND (67)
- Donna Kingelin IND (65)
- Samir Manji IND (52)
- Aladin Mawani IND (69)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 1st, 2012
- Public Since
- March 17th, 1980
- No. of Employees
- 22,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange- Shares in Issue
- 83,817,909
- Address
- 3000 Steeles Avenue East, Suite 400, MARKHAM, L3R 4T9
- Web
- https://www.extendicare.com/
- Phone
- +1 9054704000
- Auditors
- KPMG LLP
Upcoming Events for EXE
Q1 2025 Extendicare Inc Earnings Release
Q1 2025 Extendicare Inc Earnings Call
Extendicare Inc Annual Shareholders Meeting
Extendicare Inc Extraordinary Shareholders Meeting
Q2 2025 Extendicare Inc Earnings Release
Similar to EXE
Andlauer Healthcare
Toronto Stock Exchange
Avant Brands
Toronto Stock Exchange
dentalcorp Holdings
Toronto Stock Exchange
Lifespeak
Toronto Stock Exchange
Medical Facilities
Toronto Stock Exchange
FAQ
What is the Extendicare share price?
As of Today at 20:33 UTC, shares in Extendicare are trading at CA$13.35. This share price information is delayed by 15 minutes.
How has the Extendicare share price performed this year?
Shares in Extendicare last closed at CA$13.35 and the price had moved by +82.88% over the past 365 days. In terms of relative price strength the Extendicare share price has outperformed the Toronto Stock Exchange 300 Composite Index by +62.59% over the past year.
What are the analyst and broker recommendations for Extendicare?
The overall consensus recommendation for Extendicare is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Extendicare dividend yield?
The Extendicare dividend yield is 3.6% based on the trailing twelve month period.
Does Extendicare pay a dividend?
Last year, Extendicare paid a total dividend of CA$0.48, and it currently has a trailing dividend yield of 3.6%.Looking ahead, shares in Extendicare are due to go ex-dividend on 2025-04-30 and the next dividend pay date is 2025-05-15.
When does Extendicare next pay dividends?
Extendicare are due to go ex-dividend on 2025-04-30 and the next dividend pay date is 2025-05-15. The historic dividend yield on Extendicare shares is currently 3.6%.
How do I buy Extendicare shares?
To buy shares in Extendicare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Extendicare?
As of the previous close price of CA$13.35, shares in Extendicare had a market capitalisation of CA$1.12bn.
Where are Extendicare shares listed?
Here are the trading details for Extendicare:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: EXE
What kind of share is Extendicare?
Based on an overall assessment of its quality, value and momentum Extendicare is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Extendicare share price forecast for 2025?
The analyst consensus target price for shares in Extendicare is CA$13.54. That is 1.42% above the last closing price of CA$13.35.
Analysts covering Extendicare currently have a consensus Earnings Per Share (EPS) forecast of CA$0.76 for the next financial year.
Find out moreWhat is the trend in the Extendicare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Extendicare. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +43.95%.
As of the last closing price of CA$13.35, shares in Extendicare were trading +30.6% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Extendicare PE Ratio?
The Extendicare PE ratio based on its reported earnings over the past 12 months is 16.86. The shares last closed at CA$13.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Extendicare?
Extendicare's management team is headed by:
- Alan Torrie - NEC
- Michael Guerriere - PRE
- David Bacon - CFO
- Liselie Sarauer - CHO
- John Toffoletto - SVP
- Jillian Fountain - VPR
- Elaine Everson - VPR
- Ali Mir - VPR
- Lisa Pearson - VPR
- Norma Beauchamp - IND
- Sandra Hanington - IND
- Alan Hibben - IND
- Brent Houlden - IND
- Donna Kingelin - IND
- Samir Manji - IND
- Aladin Mawani - IND